Search results
The Push to Get More People Into Long COVID Studies
Medscape· 16 hours agoSince then, it's been a tough road for Spier, 37, who said he wouldn't wish his hellish condition on anyone. Last spring, he enrolled in a clinical trial...
Fauci testifies about COVID pandemic response at heated House hearing
CBS News· 1 day agoDr. Anthony Fauci testified on Monday before a Republican-led House panel investigating the origins...
...Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, ...
St. Joseph News-Press· 6 days agoNo matter how much a virus changes in the field, it uses the same "landing sites" in the host body...
Levels of COVID in Mass. wastewater tick up with arrival of new ‘FLiRT’ variants - The Boston Globe
The Boston Globe· 6 days agoDoron called the increase “very, very, very gradual.” “Certainly it’s nothing like when Omicron was...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 6 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoThe pharmaceutical company's EPS Rating, a measure of profitability, is 33 out of a best-possible...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 4 days agoFood and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of...
What’s next for bird flu vaccines
Technology Review· 5 days agoMost of the flu virus used in vaccines is grown in eggs, but there are alternatives. The seasonal flu vaccine Flucelvax, produced by CSL Seqirus, is...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoCoupled with Invivyd’s proprietary mAb technology platform and engineering capabilities, this pathway provides the company with the opportunity to rapidly, efficiently, and durably deliver high ...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 5 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
